{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:34:40Z","timestamp":1787758480030,"version":"build-2784847793"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Quinazolinone and quinazoline have been shown different pharmacological activities, namely anticancer, anti-inflammatory, anti-hyperlipidemia, analgesic, antihypertensive, and antibacterial. On the other hand, molecular hybridization is a structural modification technique in the design of new ligands which consist of two or more pharmacologically active molecules in one structure. Therefore, due to the importance of the biological activities of quinazolinones for the development of new therapeutic agents, this review emphasizes current findings on various quinazolinone-based hybrids in medicinal chemistry. Moreover, it highlights the biological activities and structure-activity relationship of these hybrids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jrms.jrms_1025_21","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T07:30:42Z","timestamp":1664263842000},"page":"68","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Quinazolinone-based hybrids with diverse biological activities"],"prefix":"10.4103","volume":"27","author":[{"given":"Rezvan","family":"Rezaeinasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadamali","family":"Khodarahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-68-20240830","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0065-2725(08)60527-9","article-title":"A Text Book of Quinazolines","volume":"1","author":"Armarego","year":"1963","journal-title":"Adv Heterocyle Chem"},{"key":"R2-68-20240830","first-page":"453","article-title":"Synthesis and pharmacological evaluation of 3-alkyl\/aryl-2-methylquinazolin-4-one derivatives","volume":"2","author":"Ranawat","year":"2011","journal-title":"Int J Drug Des Discov"},{"key":"R3-68-20240830","first-page":"365","article-title":"A novel route to the niementowski reaction","volume":"76","author":"Kidwai","year":"2003","journal-title":"Croat Chem Acta"},{"key":"R5-68-20240830","doi-asserted-by":"crossref","first-page":"148","DOI":"10.9767\/bcrec.9.2.6794.148-154","article-title":"Selective solvent-free biginelli condensation using tungstate sulfuric acid as powerful and reusable catalyst","volume":"9","author":"Nasab","year":"2014","journal-title":"Bull Chem React Eng Catal"},{"key":"R6-68-20240830","doi-asserted-by":"crossref","first-page":"580086","DOI":"10.3389\/fchem.2020.580086","article-title":"Microwave-assisted synthesis of quinazolines and quinazolinones: An overview","volume":"8","author":"Mohammadkhani","year":"2020","journal-title":"Front Chem"},{"key":"R7-68-20240830","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1747519819857513","article-title":"A convenient method for the synthesis of 3,4-dihydroquinazolines from iminoester hydrochlorides via microwave irradiation","volume":"43","author":"Karaali","year":"2019","journal-title":"J Chem Res"},{"key":"R8-68-20240830","doi-asserted-by":"crossref","first-page":"41353","DOI":"10.1039\/D0RA06642G","article-title":"Recent advances in the pharmacological diversification of quinazoline\/quinazolinone hybrids","volume":"10","author":"Auti","year":"2020","journal-title":"RSC Adv"},{"key":"R9-68-20240830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: A comparative patent review (2011-2016)","volume":"28","author":"Hameed","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"R10-68-20240830","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ejmech.2007.06.010","article-title":"Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines","volume":"43","author":"Chandrika","year":"2008","journal-title":"Eur J Med Chem"},{"key":"R11-68-20240830","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4103\/1735-5362.217425","article-title":"Synthesis, characterization, cytotoxic screening, and density functional theory studies of new derivatives of quinazolin-4(3H)-one Schiff bases","volume":"12","author":"Nasab","year":"2017","journal-title":"Res Pharm Sci"},{"key":"R12-68-20240830","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1747-0285.2007.00548.x","article-title":"Synthesis of novel 3-butyl-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents","volume":"70","author":"Alagarsamy","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"R13-68-20240830","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm9505122","article-title":"High-affinity inhibitors of dihydrofolatereductase: Antimicrobial and anticancer activities of 7,8-dialkyl-1,3-diaminopyrrolo[3,2-f]quinazolines with small molecular size","volume":"39","author":"Kuyper","year":"1996","journal-title":"J Med Chem"},{"key":"R14-68-20240830","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4103\/1735-5362.213988","article-title":"Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives","volume":"12","author":"Nasab","year":"2017","journal-title":"Res Pharm Sci"},{"key":"R15-68-20240830","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bmcl.2007.10.027","article-title":"Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines","volume":"18","author":"Verhaeghe","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"R16-68-20240830","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0163-7258(99)00055-8","article-title":"The effect of side-chain, para-aminobenzoyl region, and B-ring modifications on dihydrofolatereductase binding, influx via the reduced folate carrier, and cytotoxicity of the potent nonpolyglutamatableantifolate N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine","volume":"85","author":"Rosowsky","year":"2000","journal-title":"Pharmacol Ther"},{"key":"R17-68-20240830","first-page":"65","article-title":"[4-(6,7-Disubstituted quinazolin-4-ylamino) phenyl] carbamic acid esters: A novel series of dual EGFR\/VEGFR-2 tyrosine kinase inhibitors","volume":"2","author":"Garofalo","year":"2011","journal-title":"RSC Med Chem"},{"key":"R18-68-20240830","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","article-title":"Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases","volume":"19","author":"Ivasiv","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"R19-68-20240830","doi-asserted-by":"crossref","first-page":"28313","DOI":"10.1039\/C6RA24662A","article-title":"Small hybrid heteroaromatics: Resourceful biological tools in cancer research","volume":"7","author":"Abbot","year":"2017","journal-title":"RSC Adv"},{"key":"R20-68-20240830","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015-2016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur J Med Chem"},{"key":"R21-68-20240830","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","article-title":"Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: An update on the development of synthetic methods and pharmacological diversification","volume":"24","author":"Khan","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"R22-68-20240830","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/1735-5362.268201","article-title":"Synthesis and cytotoxic evaluation of some quinazolinone-5-(4chlorophenyl)1,3,4-oxadiazole conjugates","volume":"14","author":"Hassanzadeh","year":"2019","journal-title":"Res Pharm Sci"},{"key":"R23-68-20240830","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/1735-5362.253360","article-title":"Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids","volume":"14","author":"Hassanzadeh","year":"2019","journal-title":"Res Pharm Sci"},{"key":"R24-68-20240830","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2174\/13895575113139990073","article-title":"An evolving role of piperazine moieties in drug design and discovery","volume":"13","author":"Patel","year":"2013","journal-title":"Mini Rev Med Chem"},{"key":"R25-68-20240830","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1016\/j.bmcl.2016.08.060","article-title":"Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position","volume":"26","author":"Zhang","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"R26-68-20240830","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0960-894X(01)00190-1","article-title":"Antitumor agents. Part 204: Synthesis and biological evaluation of substituted 2-aryl quinazolinones","volume":"11","author":"Xia","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"R28-68-20240830","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bmc.2009.12.015","article-title":"Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents","volume":"18","author":"Kamal","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"R29-68-20240830","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.bmcl.2016.07.003","article-title":"DABCO-catalyzed one-pot three component synthesis of dihydropyrano[3,2-c]chromene substituted quinazolines and their evaluation towards anticancer activity","volume":"26","author":"Vodnala","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"R30-68-20240830","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/j.bmc.2013.08.051","article-title":"Quinazolino linked 4\u03b2-amidopodophyllotoxin conjugates regulate angiogenic pathway and control breast cancer cell proliferation","volume":"21","author":"Kamal","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"R31-68-20240830","first-page":"975","article-title":"Synthesis, characterization, molecular docking studies and biological evaluation of some novel hybrids based on quinazolinone, benzofuran and imidazolium moieties as potential cytotoxic and antimicrobial agents","volume":"20","author":"Asadi","year":"2017","journal-title":"Iran J Basic Med Sci"},{"key":"R32-68-20240830","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pharmthera.2015.01.008","article-title":"Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs","volume":"150","author":"Murray","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R33-68-20240830","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.apcsb.2015.08.001","article-title":"Chapter two \u2013 Antitumor lipids \u2013 Structure, functions, and medical applications","volume":"101","author":"Kostadinova","year":"2015","journal-title":"Adv Protein Chem Struct Biol"},{"key":"R34-68-20240830","doi-asserted-by":"crossref","first-page":"742","DOI":"10.18433\/J3CW23","article-title":"Alkylphospholipids \u2013 A promising class of chemotherapeutic agents with a broad pharmacological spectrum","volume":"16","author":"Pachioni Jde","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"R35-68-20240830","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s002800051114","article-title":"Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma","volume":"44","author":"Clive","year":"1999","journal-title":"Cancer Chemother Pharmacol"},{"key":"R36-68-20240830","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12272-017-0977-z","article-title":"Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents","volume":"41","author":"Alam","year":"2018","journal-title":"Arch Pharm Res"},{"key":"R37-68-20240830","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nrc2947","article-title":"Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer","volume":"10","author":"Pao","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R38-68-20240830","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bioorg.2018.11.021","article-title":"Design, synthesis and cytotoxicity of chimeric erlotinib-alkylphospholipid hybrids","volume":"84","author":"Alam","year":"2019","journal-title":"Bioorg Chem"},{"key":"R39-68-20240830","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bioorg.2018.07.015","article-title":"Dual EGFR\/HER2 inhibitors and apoptosis inducers: New benzo[g] quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers","volume":"80","author":"Ghorab","year":"2018","journal-title":"Bioorg Chem"},{"key":"R40-68-20240830","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ejmech.2009.11.008","article-title":"Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring","volume":"45","author":"Bharti","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R41-68-20240830","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.ejmech.2009.06.002","article-title":"Synthesis and antibacterial activity of some new thiazole and thiophene derivatives","volume":"44","author":"Khalil","year":"2009","journal-title":"Eur J Med Chem"},{"key":"R42-68-20240830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0928-0987(99)00038-X","article-title":"Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4\u2019-chlorophenyl) thiazol-2-yl] thiosemicarbazide","volume":"9","author":"Pandeya","year":"1999","journal-title":"Eur J Pharm Sci"},{"key":"R43-68-20240830","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejmech.2005.01.013","article-title":"Synthesis, antibacterial and antifungal activity of some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring","volume":"41","author":"Cukurovali","year":"2006","journal-title":"Eur J Med Chem"},{"key":"R44-68-20240830","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cbi.2009.12.008","article-title":"3-(4-(Benzo[d] thiazol-2-yl)-1-phenyl-1H-pyrazol-3-yl) phenyl acetate induced Hep G2 cell apoptosis through a ROS-mediated pathway","volume":"183","author":"Li","year":"2010","journal-title":"Chem Biol Interact"},{"key":"R45-68-20240830","first-page":"210","article-title":"Synthesis and cytotoxicity evaluation of some new 6-nitro derivatives of thiazole-containing 4-(3H)-quinazolinone","volume":"11","author":"Hosseinzadeh","year":"2016","journal-title":"Res Pharm Sci"},{"key":"R46-68-20240830","first-page":"861","article-title":"Synthesis, reaction and antimicrobial activity of some pyridinethione derivatives containing benzimidazole nucleus","volume":"2","author":"Zohdi","year":"2014","journal-title":"Int J Adv Res"},{"key":"R47-68-20240830","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhet.293","article-title":"1H -Benzimidazole-2-acetonitriles as synthon in fused benzimidazole synthesis","volume":"47","author":"Dawood","year":"2010","journal-title":"J Heterocycl Chem"},{"key":"R48-68-20240830","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1016\/j.ejmech.2010.09.050","article-title":"Synthesis, antitrichinnellosis and antiprotozoal activity of some novel thieno[2,3-d]pyrimidin-4(3H)-ones containing benzimidazole ring","volume":"45","author":"Mavrova","year":"2010","journal-title":"Eur J Med Chem"},{"key":"R49-68-20240830","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/1735-5362.258493","article-title":"Synthesis and cytotoxic evaluation of novel quinozalinone derivatives with substituted benzimidazole in position 3","volume":"14","author":"Taherian","year":"2019","journal-title":"Res Pharm Sci"},{"key":"R50-68-20240830","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1038\/s41598-020-62977-x","article-title":"Synthesis, biological activity and molecular modeling study of novel 1,2,4-triazolo[4,3-b][1,2,4,5]tetrazines and 1,2,4-triazolo[4,3-b][1,2,4]triazines","volume":"10","author":"El-Reedy","year":"2020","journal-title":"Sci Rep"},{"key":"R51-68-20240830","first-page":"149","article-title":"1,2,4-triazine derivatives: Synthesis and biological applications","volume":"5","author":"Arshad","year":"2014","journal-title":"IJPSR"},{"key":"R52-68-20240830","first-page":"19","article-title":"Sulfones: An important class of organic compounds with diverse biological activities","volume":"7","author":"Ahmad","year":"2015","journal-title":"IJPSR"},{"key":"R53-68-20240830","first-page":"1","article-title":"Design, synthesis, and biological evaluation of triazolyl- and triazinyl-quinazolinediones as potential antitumor agents","volume":"2019","author":"Al-Romaizan","year":"2019","journal-title":"J Chem"},{"key":"R54-68-20240830","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/1389557516666160211120835","article-title":"Synthesis and biological activities of oxadiazole derivatives: A review","volume":"16","author":"Vaidya","year":"2016","journal-title":"Mini Rev Med Chem"},{"key":"R55-68-20240830","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-120611-144851","article-title":"Ataluren as an agent for therapeutic nonsense suppression","volume":"64","author":"Peltz","year":"2013","journal-title":"Annu Rev Med"},{"key":"R56-68-20240830","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1134\/S1070363219120260","article-title":"Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-isoxazole linked quinazoline derivatives as anticancer agents","volume":"89","author":"Srinivas","year":"2019","journal-title":"Russ J Gen Chem"},{"key":"R57-68-20240830","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.1016\/j.bmc.2007.05.037","article-title":"Synthesis, characterization and antimicrobial activity of new aliphatic sulfonamide","volume":"15","author":"Ozbek","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R58-68-20240830","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/jm010888h","article-title":"S(+)-4-(1-Phenylethylamino) quinazolines as inhibitors of human immunoglobuline E synthesis: Potency is dictated by stereochemistry and atomic point charges at N-1","volume":"44","author":"Berger","year":"2001","journal-title":"J Med Chem"},{"key":"R59-68-20240830","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molstruc.2018.04.055","article-title":"Synthesis, characterization, crystal structure, Hirshfeld interaction and bio-evaluation studies of 4-amino quinazoline sulfonamide derivatives","volume":"1167","author":"Kumar","year":"2018","journal-title":"J Mol Struct"},{"key":"R60-68-20240830","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1007\/s00044-012-0320-7","article-title":"Synthesis and in vitro antimicrobial activity of some newer quinazolinone-sulfonamide linked hybrid heterocyclic entities derived from glycine","volume":"22","author":"Vanparia","year":"2013","journal-title":"Med Chem Res"},{"key":"R61-68-20240830","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1016\/S0040-4020(03)01099-8","article-title":"Recent progress in the synthesis and chemistry of azetidinones","volume":"59","author":"Singh","year":"2003","journal-title":"Tetrahedron"},{"key":"R62-68-20240830","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1007\/s00044-011-9808-9","article-title":"Design, synthesis, and in vitro antimicrobial activities of novel azetidinyl-3-quinazolin-4-one hybrids","volume":"21","author":"Myangar","year":"2012","journal-title":"Med Chem Res"},{"key":"R63-68-20240830","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/ar200041k","article-title":"Chemistry of Ni2+ in urease: Sensing, trafficking, and catalysis","volume":"44","author":"Zambelli","year":"2011","journal-title":"Acc Chem Res"},{"key":"R64-68-20240830","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/mr.53.1.85-108.1989","article-title":"Microbial ureases: Significance, regulation, and molecular characterization","volume":"53","author":"Mobley","year":"1989","journal-title":"Microbiol Rev"},{"key":"R65-68-20240830","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/14756360903389864","article-title":"Design, synthesis, and urease inhibition studies of some 1,3,4-oxadiazoles and 1,2,4-triazoles derived from mandelic acid","volume":"25","author":"Akhtar","year":"2010","journal-title":"J Enzyme Inhib Med Chem"},{"key":"R67-68-20240830","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bioorg.2018.10.031","article-title":"Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities","volume":"83","author":"Mente\u015fe","year":"2019","journal-title":"Bioorg Chem"},{"key":"R68-68-20240830","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1021\/jm0613166","article-title":"Structural and functional basis of cyclooxygenase inhibition","volume":"50","author":"Blobaum","year":"2007","journal-title":"J Med Chem"},{"key":"R69-68-20240830","first-page":"1119","article-title":"Quinazoline derivatives with potent anti-inflammatory and anti-allergic activities","volume":"6","author":"Chandrika","year":"2008","journal-title":"Int J Chem Sci"},{"key":"R70-68-20240830","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bioorg.2018.11.030","article-title":"1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1\/2 inhibitory activity and molecular docking study","volume":"84","author":"Sakr","year":"2019","journal-title":"Bioorg Chem"},{"key":"R71-68-20240830","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1074\/jbc.M110.194860","article-title":"Inhibition of \u03b2-secretase in vivo via antibody binding to unique loops (D and F) of BACE1","volume":"286","author":"Zhou","year":"2011","journal-title":"J Biol Chem"},{"key":"R72-68-20240830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","article-title":"Developing \u03b2-secretase inhibitors for treatment of Alzheimer's disease","volume":"120","author":"Ghosh","year":"2012","journal-title":"J Neurochem"},{"key":"R73-68-20240830","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bioorg.2017.07.014","article-title":"Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease","volume":"74","author":"Haghighijoo","year":"2017","journal-title":"Bioorg Chem"},{"key":"R74-68-20240830","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbapap.2005.05.010","article-title":"Type 2 diabetes \u2013 Therapy with dipeptidyl peptidase IV inhibitors","volume":"1751","author":"Demuth","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"R75-68-20240830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bioorg.2017.02.004","article-title":"Design and synthesis of quinazoline-3,4-(4H)-diamine endowed with thiazoline moiety as new class for DPP-4 and DPPH inhibitor","volume":"71","author":"Ali","year":"2017","journal-title":"Bioorg Chem"},{"key":"R76-68-20240830","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1016\/j.bmc.2017.10.041","article-title":"Ionic liquid mediated stereoselective synthesis of alanine linked hybrid quinazoline-4(3H)-one derivatives perturbing the malarial reductase activity in folate pathway","volume":"25","author":"Patel","year":"2017","journal-title":"Bioorg Med Chem"}],"container-title":["Journal of Research in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_1025_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:15:02Z","timestamp":1787757302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jrms.jrms_1025_21"}},"subtitle":["A mini-review"],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jrms.jrms_1025_21","relation":{},"ISSN":["1735-1995"],"issn-type":[{"value":"1735-1995","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}